Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies

Most targeted cancer therapies fail to achieve complete tumor regressions or attain durable remissions. To understand why these treatments fail to induce robust cytotoxic responses despite appropriately targeting oncogenic drivers, here we systematically interrogated the dependence of cancer cells o...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero, Joan, Gstalder, Cécile, Kim, Daniel J., Sadowicz, Dorota, Miles, Wayne, Manos, Michael, Cidado, Justin R., Paul Secrist, J., Tron, Adriana E., Flaherty, Keith, Stephen Hodi, F., Yoon, Charles H., Letai, Anthony, Fisher, David E., Haq, Rizwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856172/
https://www.ncbi.nlm.nih.gov/pubmed/31727958
http://dx.doi.org/10.1038/s41467-019-12477-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856172/
https://www.ncbi.nlm.nih.gov/pubmed/31727958
http://dx.doi.org/10.1038/s41467-019-12477-y

Ejemplares similares